Targeting Innovation in Antibiotic Drug Discovery

The need for a One Health – One Europe – One World Framework

Principal Investigator: Elias Mossialos
Researchers: Victoria Simpkin
Start Date: 01 December 2016
End Date: 30 November 2017
Region: Europe, Americas, Asia
Keywords: antimicrobial resistance, antibiotic innovation, health policy

Antimicrobial resistance is a topic of pressing global concern. LSE Health was commissioned by the Dutch Government, as part of their 2016 Presidency of the EU, to produce a review of current incentives for antibiotic innovation. This report builds on the 2010 study commissioned by the Swedish government to examine incentive mechanisms for encouraging antibiotic development. The findings were published by the WHO’s European Observatory on Health Systems and Policies. The book offers an in-depth review and critical analysis of existing European and international initiatives supporting innovation of novel antibiotics as well as a set of policy recommendations for improving the global and European research and development agendas for antibiotics. The outcome of this review provided a platform for discussion among European Ministers of Health and Ministers of Agriculture during the 2016 Ministerial Conference on AMR.


Targeting innovation in antibiotic drug discovery and development

Check back later for our latest Twitter updates.

Contact us


LSE Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE

Follow us